artemether has been researched along with artenimol in 133 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (5.26) | 18.7374 |
| 1990's | 23 (17.29) | 18.2507 |
| 2000's | 35 (26.32) | 29.6817 |
| 2010's | 46 (34.59) | 24.3611 |
| 2020's | 22 (16.54) | 2.80 |
| Authors | Studies |
|---|---|
| Combrinck, J; de Kock, C; N'Da, DD; Smit, FJ; Smith, PJ; Zuma, NH | 1 |
| Dong, G; Liu, N; Sheng, C; Wang, Y; Wu, S | 1 |
| Emami, SA; Taleghani, A; Tayarani-Najaran, Z | 1 |
| Brossi, A; Buchs, P; Dominguez Gerpe, L; Flippen-Anderson, JL; Luo, XD; Milhous, W; Peters, W; Venugopalan, B; Yeh, HJ | 1 |
| el-Feraly, FS; Kampinga, HH; Konings, AW; Malingré, TM; Moskal, TA; Pras, N; Woerdenbag, HJ | 1 |
| Kan, KW; Maggs, JL; O'Neill, PM; Park, BK; Raynes, K; Searle, NL; Storr, RC; Ward, SA | 1 |
| Ager, AL; Andersen, SL; Dong, Y; Edwards, G; Fu, H; Gerena, L; Holme, AD; Kyle, DE; McLean, WG; Milhous, WK; Miller, RE; Vennerstrom, JL; Walters, SM; Wesche, DL; Wood, JK | 1 |
| Bishop, LP; Hindley, S; Maggs, JL; Miller, A; O'Neill, PM; Park, BK; Posner, GH; Roberts, SM; Scheinmann, F; Stachulski, AV; Ward, SA | 1 |
| Brun, R; Charman, SA; Charman, WN; Chiu, FC; Chollet, J; Dong, Y; Dorn, A; Karle, JM; Matile, H; Santo Tomas, J; Scheurer, C; Scorneaux, B; Snyder, C; Tang, Y; Urwyler, H; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
| ElSohly, MA; Galal, AM; Jacob, M; Ross, SA | 1 |
| Adagu, IS; Fivelman, QL; Warhurst, DC | 1 |
| Dembitsky, VM | 1 |
| Charman, SA; Charman, WN; Chiu, FC; Creek, DJ; Dong, Y; Prankerd, RJ; Vennerstrom, JL | 1 |
| Gottstein, B; Hemphill, A; Keiser, J; Lany, C; Ortega-Mora, LM; Roethlisberger, C; Spicher, M; Stadelmann, B | 1 |
| Chadwick, J; Cosstick, R; Mercer, AE; O'Neill, PM; Park, BK | 1 |
| Baird, J; Bray, PG; Charidza, T; Cosstick, R; Davies, J; Janneh, O; Jones, M; Kennedy, ME; La Pensée, LJ; Mercer, AE; O'Neill, PM; Park, BK; Piantanida, I; Rawe, SL; Stocks, PA; Ward, SA | 1 |
| Charman, SA; Charman, WN; Chiu, FC; Creek, DJ; Prankerd, RJ; Ryan, E; Vennerstrom, JL | 1 |
| Chung, WY; Jung, M; Lee, Y; Moon, HI; Park, KK; Park, N | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Edwards, G; Thomas, CG; Ward, SA | 1 |
| Song, ZY; Zhao, KC | 1 |
| Gu, HM; Peters, W; Warhurst, DC | 3 |
| Li, ZL; Peters, W; Robinson, BL; Warhurst, DC | 1 |
| Gu, HM; Li, ZL; Peters, W; Warhurst, DC | 1 |
| Asokan, M; Chin, LK; Mansor, SM; Mordi, MN; Nair, NK; Navaratnam, V | 1 |
| Mberu, EK; Muhia, DK; Watkins, WM | 1 |
| Ager, AL; Klayman, DL; Lin, AJ | 1 |
| Edwards, G; Mberu, EK; Muhia, DK; Thomas, CG; Ward, SA; Watkins, WM | 1 |
| Edwards, G; Karbwang, J; Na Bangchang, K; Sukontason, K; Thanavibul, A; Thomas, CG; Ward, SA | 1 |
| Davis, TM; Johnston, WA; Manning, LS; Skinner, TS | 1 |
| Banmairuroi, V; Congpuong, K; Karbwang, J; Molunto, P; Na-Bangchang, K | 1 |
| Donker, M; Godbillon, J; Netter, C; Sandrenan, N; Sioufi, A; van Valkenburg, C | 1 |
| Mansor, SM; Mordi, MN; Navaratnam, V; Wernsdorfer, WH | 1 |
| Brewer, TG; Fleckenstein, LL; Heiffer, MH; Li, QG; Masonic, K; Peggins, JO | 1 |
| Berens, RL; Curiel, TJ; Krug, EC; Nash, PB | 1 |
| Congpuong, K; Karbwang, J; Molunto, P; Na-Bangchang, K; Thanavibul, A; Wattanakoon, Y | 1 |
| Karbwang, J; Molunto, P; Na-Bangchang, K; Thanavibul, A | 1 |
| Harinasuta, T; Karbwang, J; Na-Bangchang, K; Rimchala, W; Sukontason, K; Tin, T | 1 |
| Li, Y; Wu, YL | 1 |
| McLean, WG; Ward, SA | 1 |
| Cheng-Qi, S; Mull, R; Qing, JX; van Agtmael, MA; van Boxtel, CJ | 1 |
| Edwards, G; Haynes, RK; Khalid, SA; Mohamed, SS; Tang, HP; Wan, TS; Ward, SA; Zheng, M | 1 |
| Gupta, V; van Agtmael, MA; van Boxtel, CJ; van der Graaf, CA | 1 |
| Dodd, CC; Edwards, G; McLean, WG; Park, BK; Sadler, CJ; Smith, SL; Ward, SA | 1 |
| MacDonald, RD | 1 |
| Tu, Y | 1 |
| Green, MD; Mount, DL; Wirtz, RA | 1 |
| Gauducheau, N; Richard, F; Sandrenan, N; Souppart, C | 1 |
| Chen, YG; Yu, BY | 1 |
| Brittenham, GM; Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S | 1 |
| Aarons, L; Edwards, G; Kokwaro, GO; Majid, O; Marsh, K; Mithwani, S; Mohamed, S; Muchohi, S; Watkins, W | 1 |
| Gabriëls, M; Plaizier-Vercammen, J | 1 |
| Shen, WJ; Thiero, M | 1 |
| Keiser, J; Shu-Hua, X; Tanner, M; Utzinger, J | 1 |
| Ashley, EA; La, Y; Lindegardh, N; McGready, R; Nosten, F; Singhasivanon, P; Stepniewska, K; White, NJ | 1 |
| Atemnkeng, MA; De Cock, K; Plaizier-Vercammen, J | 1 |
| Ayede, I; Dada-Adegbola, HO; Fadero, FF; Falade, AG; Falade, CO; Gbotosho, GO; Happi, CT; Oduola, AM; Salako, LA | 1 |
| Davis, TM; Ilett, KF; Karunajeewa, HA; Manning, L; Mueller, I | 1 |
| Bukirwa, H; Dorsey, G; Kamya, MR; Lugemwa, M; Rosenthal, PJ; Rwakimari, JB; Staedke, SG; Talisuna, A; Wabwire-Mangen, F; Yeka, A | 1 |
| Christophel, E; Hu, XM; Lin, SG; Liu, J; Meng, F; Wang, GZ; Wang, SQ; Zeng, LH | 1 |
| Hou, J; Wang, D; Wang, H; Zhang, R | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Dorsey, G; Nosten, F; Price, RN | 1 |
| Aweeka, FT; Huang, L; Jayewardene, AL; Li, X; Lizak, PS; Marzan, F | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| Arinaitwe, E; Bigira, V; Dorsey, G; Gasasira, A; Homsy, J; Kakuru, A; Kamya, MR; Katrak, S; Sandison, TG; Tappero, JW; Wanzira, H | 1 |
| Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
| Annerberg, A; Ashton, M; Björkman, A; Dahlström, S; Färnert, A; Gil, P; Hietala, SF; Lindegårdh, N; Mårtensson, A; Ngasala, B; Premji, Z | 1 |
| Arinaitwe, E; Bigira, V; Creek, D; Dorsey, G; Kakuru, A; Kamya, MR; Sandison, TG; Tappero, J; Wanzira, H | 1 |
| Ali, S; Lindegardh, N; Najmi, MH; Tarning, J | 1 |
| Day, NP; Hanpithakpong, W; Kamanikom, B; Lindegardh, N; Singhasivanon, P; White, NJ | 1 |
| Bai, KH; Liu, T; Wang, RL; Xing, J; Zhang, LF; Zhang, SQ | 1 |
| Duthaler, U; Huwyler, J; Keiser, J | 1 |
| Dai, JR; Li, HJ; Li, YZ; Liang, YS; Qu, GL; Tao, YH; Wang, W; Wei, JY; Xing, YT | 1 |
| Faye, B; Faye, O; Kane, D; Kassi, KF; Kiki Barro, CP; Kone, M; Kuete, T; Menan, H; N'diaye, JL; Oga, AS; Same-Ekobo, A; Tine, R; Vicky, AM; Yavo, W | 1 |
| Davis, TM; Hwaiwhanje, I; Karunajeewa, HA; Laman, M; Manning, L; Morep, N; Mueller, I; Page-Sharp, M; Salman, S; Siba, P | 1 |
| Jessing, KK; Juhler, RK; Strobel, BW | 1 |
| Du, F; Liu, T; Xing, J; Zhu, F | 1 |
| Bashraheil, M; Bassat, Q; González, R; Kipkeu, C; Lefèvre, G; Lyimo, J; Machevo, S; Maiga, H; Mårtensson, A; Menéndez, C; Nahum, A; Nwaiwu, O; Ogutu, B; Ouma, P; Ubben, D; Walter, V | 1 |
| Day, NP; Dhorda, M; Guerin, PJ; Kloprogge, F; Lindegardh, N; Muwanga, S; Nosten, F; Nuengchamnong, N; Piola, P; Tarning, J; Turyakira, E; White, NJ | 1 |
| Ahnoff, M; Blessborn, D; Kaewkhao, K; Sköld, K; Sköld, O; Zeeberg, D | 1 |
| Achan, J; D'Alessandro, U; Talisuna, AO; Tibenderana, J; Yeka, A | 1 |
| Back, DJ; Byakika-Kibwika, P; Hanpithakpong, W; Khoo, SH; Lamorde, M; Lefèvre, G; Mayito, J; Merry, C; Nabukeera, L; Ryan, M | 1 |
| Aweeka, FT; Gingrich, D; Huang, L; Olson, A | 1 |
| Dhorda, M; Guerin, PJ; Jullien, V; Kloprogge, F; Nosten, F; Piola, P; Tarning, J; White, NJ | 1 |
| Cui, L; Cui, Y; Wang, B; Wang, M; Yan, G; Zhou, G | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Ashton, M; Ericsson, T; Hoffmann, KJ; Sundell, J; Torkelsson, A | 1 |
| Li, GX; Wang, W; Wang, YH; Xu, FL; Zhang, XG; Zhao, SS | 1 |
| de Vries, R; Hendriks, G; Hilhorst, MJ; Hillewaert, V; van de Merbel, NC; Verhaege, T | 1 |
| Batty, KT; Senarathna, SM | 1 |
| Wang, FY; Wang, YB; Wei, DD; Wei, YB; Yin, B; Yu, ZH; Zhang, BG; Zhao, GH | 1 |
| Bertinaria, M; Carvalho, LJ; Frangos, JA; Fruttero, R; Gasco, A; Guglielmo, S; Hofer, A; Marini, E; Martins, YC; Orjuela-Sanchez, P; Zanini, GM | 1 |
| Adedeji, WA; Adewole, IF; Akinyinka, OO; Aweeka, FT; Darin, KM; Fehintola, F; Huang, L; Morse, GD; Murphy, RL; Olson, A; Parikh, S; Scarsi, KK; Taiwo, BO | 1 |
| Bonfill, M; Cusido, RM; Dilshad, E; Mirza, B; Ramirez Estrada, K | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Achan, J; Aweeka, F; Huang, L; Kajubi, R; Kiconco, S; Mwebaza, N; Mwima, MW; Nguyen, VK; Nyunt, MM; Parikh, S; Ssebuliba, J | 1 |
| Barnes, KI; Cohen, K; Kredo, T; Maartens, G; Mauff, K; Smith, PJ; Van der Walt, JS; Wiesner, L; Workman, L | 1 |
| Chavchich, M; Diagana, TT; Edstein, MD; Rowcliffe, K; Van Breda, K | 1 |
| Bélard, S; Damm, G; Kim, J; Kurth, F; Lingscheid, T; Mayer, B; Menner, N; Pongratz, P; Salama, A; Seehofer, D; Stegemann, MS; Steiner, F; Suttorp, N; von Bernuth, H; Zoller, T | 1 |
| Iyengar, K; Roepe, PD; Siriwardana, A | 1 |
| Kofoed, PE; Rodrigues, A; Rombo, L; Ursing, J | 1 |
| Wang, S; Xu, Z | 1 |
| Ali, S; Farhat, K; Jafery, N; Waheed, A | 1 |
| Gao, H; Hou, S; Liu, H; Su, R; Sun, J; Yang, Y | 1 |
| Agaba, S; de Vries, PJ; Dorlo, TPC; Kaligirwa, N; Karlsson, MO; Lohy Das, J; Mens, PF; Rulisa, S; Tarning, J | 1 |
| Dai, R; Dai, T; Guo, Z; Jiang, W; Xie, Y | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Badjanga, BB; Day, NPJ; Fanello, C; Hoglund, RM; Jackson, NV; Kabedi, C; Kayembe, D; Lee, SJ; McGready, R; Nosten, F; Onyamboko, MA; Tarning, J; Turner, GDH; White, NJ | 1 |
| Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S | 1 |
| Barbieri, D; Blaud, M; Clain, J; Duval, R; Grougnet, R; Hammad, K; Houzé, S; Lavazec, C; Leproux, P; Maciuk, A; Michel, S; Neveu, G; Rondepierre, L; Sissoko, A; Vásquez-Ocmín, P | 1 |
| Gille, L; Machín, L; Monzote, L; Nápoles, R | 1 |
| Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B | 1 |
| Assefa, DG; Makonnen, E; Yismaw, G | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Grundmann, O; Hernandez Maldonado, J | 1 |
| Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N | 1 |
| Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z | 1 |
| Abongo, G; Basara, BB; Baseke, J; Bongo, GS; Day, NJP; Dhorda, M; Dondorp, AM; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Peerawaranun, P; Tarning, J; Taya, C; Taylor, WR; Titin, H; Uyoga, S; Waithira, N; Weere, W; Williams, TN | 1 |
| Chen, Y; Cheng, Y; Li, P; Liu, H; Lu, X; Ma, Y; Song, C; Wang, Y; Zhang, Z | 1 |
| Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F | 1 |
| Deng, YN; Guh, JH; Hsu, LC; Hsu, YF; Huang, TE; Kung, FL; Marchesi, E; Marchetti, P; Navacchia, ML; Perrone, D | 1 |
| Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA | 1 |
| Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A | 1 |
| Bamisaiye, A; Basara, BB; Baseke, J; Day, NPJ; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Taya, C; Taylor, WRJ; Titin, H; Uyoga, S; Were, W; Williams, TN | 1 |
14 review(s) available for artemether and artenimol
| Article | Year |
|---|---|
Tackling Fungal Resistance by Biofilm Inhibitors.
Topics: Animals; Antifungal Agents; Biofilms; Drug Discovery; Drug Resistance, Fungal; Fungi; Humans; Models, Molecular; Mycoses; Small Molecule Libraries | 2017 |
Artemisia: a promising plant for the treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal | 2020 |
Bioactive peroxides as potential therapeutic agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Peroxides | 2008 |
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
Studies of qinghaosu and its active derivatives in biological materials and their pharmacokinetics.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Sesquiterpenes; Structure-Activity Relationship | 1989 |
How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Evaluation; Drug Resistance; Forecasting; Humans; Malaria, Falciparum; Medicine, Chinese Traditional; Sesquiterpenes | 1998 |
Rectal administration of artemisinin derivatives for the treatment of malaria.
Topics: Administration, Rectal; Area Under Curve; Artemether; Artemisinins; Artesunate; Humans; Malaria; Sesquiterpenes | 2007 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drugs, Chinese Herbal; Female; Malaria, Falciparum; Mice; Praziquantel; Schistosomiasis japonica; Schistosomicides | 2014 |
Mini Review - Analysis of Artemether and Dihydroartemisinin by high performance high liquid chromatography in biological fluids-issues and solutions.
Topics: Antimalarials; Artemether; Artemisinins; Body Fluids; Chemistry Techniques, Analytical; Humans | 2017 |
Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized c
Topics: Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; Hemoglobins; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic | 2021 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum | 2022 |
32 trial(s) available for artemether and artenimol
| Article | Year |
|---|---|
Differential extraction of artemether and its metabolite dihydroartemisinin from plasma and determination by high-performance liquid chromatography.
Topics: Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Sesquiterpenes; Spectrophotometry, Ultraviolet | 1994 |
Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers.
Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemisinins; Blood Specimen Collection; Chromatography, High Pressure Liquid; Drug Stability; Humans; Malaysia; Male; Sesquiterpenes; Temperature | 1997 |
Pharmacokinetics of oral artemether in Thai patients with uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Follow-Up Studies; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 1998 |
Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Resistance, Multiple; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 1998 |
Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure.
Topics: Acute Kidney Injury; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Humans; Kidney; Malaria, Falciparum; Male; Metabolic Clearance Rate; Middle Aged; Sesquiterpenes; Treatment Outcome | 1998 |
Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; China; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Models, Chemical; Sesquiterpenes; Time Factors | 1999 |
The effect of grapefruit juice on the time-dependent decline of artemether plasma levels in healthy subjects.
Topics: Administration, Oral; Adult; Antifungal Agents; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Beverages; Biological Availability; Citrus; Cross-Over Studies; Food-Drug Interactions; Humans; Male; Reference Values; Sesquiterpenes; Time Factors | 1999 |
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome; Trimethoprim | 2003 |
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Drug Administration Schedule; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Half-Life; Humans; Lumefantrine; Malaria, Falciparum; Male; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Recurrence; Remission Induction; Sesquiterpenes; Tablets; Thailand | 2006 |
Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemeter followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian childr
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Suppositories | 2007 |
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Infant; Lumefantrine; Malaria, Falciparum; Quinolines; Uganda | 2008 |
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; China; Dose-Response Relationship, Drug; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Risk Factors; Treatment Outcome; Uganda | 2009 |
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Body Temperature; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Tanzania; Treatment Outcome | 2010 |
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Quinolines; Risk; Uganda; Vomiting | 2010 |
Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Cameroon; Child; Child, Preschool; Cote d'Ivoire; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Quinolines; Senegal; Treatment Outcome; Trimethoprim; Young Adult | 2011 |
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges.
Topics: Age Factors; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Body Weight; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Time Factors; Treatment Outcome | 2011 |
Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Quinine; Quinolines; Safety; Treatment Outcome; Uganda | 2013 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Cohort Studies; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Treatment Outcome; Uganda; Young Adult | 2015 |
The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.
Topics: Adult; Anti-HIV Agents; Artemether; Artemisinins; Drug Interactions; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Lopinavir; Lumefantrine; Male; Ritonavir | 2016 |
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Guinea-Bissau; Humans; Lumefantrine; Malaria, Falciparum; Quinolines; Treatment Outcome | 2016 |
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
Topics: Adult; Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Female; Humans; Malaria, Falciparum; Pregnancy; Young Adult | 2020 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines | 2021 |
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2022 |
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, n
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Democratic Republic of the Congo; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Uganda; World Health Organization | 2023 |
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies | 2023 |
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome | 2023 |
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.
Topics: alpha-Thalassemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine | 2023 |
87 other study(ies) available for artemether and artenimol
| Article | Year |
|---|---|
Synthesis and biological evaluation of a series of non-hemiacetal ester derivatives of artemisinin.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Artemisinins; Cell Line, Tumor; Chemistry Techniques, Synthetic; CHO Cells; Cricetinae; Cricetulus; Drug Design; Esters; Humans; Plasmodium falciparum | 2016 |
Arteether, a new antimalarial drug: synthesis and antimalarial properties.
Topics: Animals; Antimalarials; Artemisinins; Magnetic Resonance Spectroscopy; Malaria; Mice; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes | 1988 |
Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Carcinoma, Ehrlich Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Cisplatin; Doxorubicin; Peroxides; Sesquiterpenes; Structure-Activity Relationship; Tetrazolium Salts; Tumor Cells, Cultured | 1993 |
Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Plasmodium falciparum; Sesquiterpenes; Spectrophotometry, Infrared | 1999 |
Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes.
Topics: Alkanes; Animals; Antimalarials; Malaria; Mice; Neurites; Neuroblastoma; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Bile; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radicals; Malaria; Male; Mice; Phenyl Ethers; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2001 |
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.
Topics: Adamantane; Animals; Antimalarials; Cell Line, Tumor; Drug Resistance; Half-Life; Malaria; Malaria, Falciparum; Mice; Micronucleus Tests; Ozone; Peroxides; Plasmodium berghei; Rats; Spiro Compounds; Structure-Activity Relationship | 2005 |
Antifungal activity of artemisinin derivatives.
Topics: Antifungal Agents; Artemisinins; Candida albicans; Combinatorial Chemistry Techniques; Cryptococcus neoformans; Microbial Sensitivity Tests; Molecular Structure | 2005 |
Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Antagonism; Drug Combinations; Drug Interactions; Drug Resistance; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes; Tritium | 2007 |
Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials.
Topics: Alkylation; Animals; Antimalarials; Artemisinins; Heme; Humans; Kinetics; Parasitic Sensitivity Tests; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship | 2008 |
In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives.
Topics: Albendazole; Animals; Anti-Infective Agents; Antiparasitic Agents; Artemisinins; Drug Therapy, Combination; Echinococcosis; Echinococcus granulosus; Echinococcus multilocularis; Humans; Larva; Mice; Mice, Inbred BALB C; Nitro Compounds; Parasitic Sensitivity Tests; Thiazoles; Treatment Outcome | 2008 |
Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Topics: Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Dimerization; HL-60 Cells; Humans; Plasmodium falciparum | 2009 |
Antitumour and antimalarial activity of artemisinin-acridine hybrids.
Topics: Acridines; Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Erythrocytes; Flow Cytometry; G1 Phase; HL-60 Cells; Humans; Plasmodium falciparum | 2009 |
Stability of peroxide antimalarials in the presence of human hemoglobin.
Topics: Antimalarials; Artemisinins; Drug Stability; Hemoglobins; Humans; Molecular Structure; Peroxides; Spectrophotometry | 2009 |
Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
Topics: Acetals; Amides; Animals; Apoptosis; Artemisinins; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Endothelium, Vascular; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Transplantation; Structure-Activity Relationship | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection.
Topics: Artemether; Artemisinins; Chromatography, High Pressure Liquid; Humans; Schistosomicides; Sesquiterpenes; Spectrophotometry, Ultraviolet | 1992 |
Hemolysis induced by artemisinin and its derivatives in vitro.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Erythrocytes; Hemoglobins; Hemolysis; Humans; Pyrans; Sesquiterpenes | 1986 |
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Malaria; Male; Mice; Pigments, Biological; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
Rapid action of Qinghaosu and related drugs on incorporation of [3H]isoleucine by Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Isoleucine; Kinetics; Plasmodium falciparum; Protein Biosynthesis; Pyrans; Sesquiterpenes; Tritium | 1983 |
Effects of qinghaosu and related compounds on incorporation of [G-3H] hypoxanthine by Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Hypoxanthine; Hypoxanthines; Plasmodium falciparum; Pyrans; Sesquiterpenes; Time Factors | 1983 |
Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro.
Topics: Anisomycin; Antimalarials; Artemether; Artemisinins; Chloroquine; Erythrocytes; Humans; Plasmodium falciparum; Pyrans; Sesquiterpenes | 1984 |
Determination of artemether and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isomerism; Male; Reference Values; Reproducibility of Results; Sesquiterpenes | 1995 |
Antimalarial activity of dihydroartemisinin derivatives by transdermal application.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Gels; Malaria; Mice; Plasmodium berghei; Sesquiterpenes; Structure-Activity Relationship | 1994 |
Ferriprotoporphyrin catalysed decomposition of artemether: analytical and pharmacological implications.
Topics: Antimalarials; Artemether; Artemisinins; Carbon Radioisotopes; Catalysis; Chromatography, High Pressure Liquid; Hemin; Hemoglobins; Hemolysis; Humans; In Vitro Techniques; Sesquiterpenes; Spectrophotometry, Ultraviolet | 1994 |
Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemether; Artemisinins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Thailand | 1994 |
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 1996 |
Determination of artemether and its major metabolite, dihydroartemisinin, in plasma using high-performance liquid chromatography with electrochemical detection.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isomerism; Male; Sensitivity and Specificity; Sesquiterpenes | 1997 |
Determination of artemether and its metabolite, dihydroartemisinin, in plasma by high-performance liquid chromatography and electrochemical detection in the reductive mode.
Topics: Acetates; Acetonitriles; Antimalarials; Artemether; Artemisinins; Autoanalysis; Chromatography, High Pressure Liquid; Drug Stability; Humans; Quality Control; Sensitivity and Specificity; Sesquiterpenes | 1997 |
The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats.
Topics: Absorption; Animals; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Availability; Bridged Bicyclo Compounds, Heterocyclic; Male; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Succinates | 1998 |
Selection and characterization of Toxoplasma gondii mutants resistant to artemisinin.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Drug Resistance; Ethyl Methanesulfonate; Female; Humans; Methylnitronitrosoguanidine; Mice; Mice, Inbred ICR; Mutagenesis; Sesquiterpenes; Toxoplasma; Toxoplasmosis, Animal | 1998 |
In vitro neurotoxicity of artemisinin derivatives.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Cell Differentiation; Central Nervous System Diseases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Mice; Microscopy, Electron; Neuroblastoma; Neurons; Reproducibility of Results; Sesquiterpenes; Tumor Cells, Cultured | 1998 |
Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Calibration; Gas Chromatography-Mass Spectrometry; Humans; Male; Reference Standards; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Sesquiterpenes | 1999 |
The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro.
Topics: Animals; Antimalarials; Antimetabolites; Antioxidants; Artemether; Artemisinins; Buthionine Sulfoximine; Drug Interactions; Glutathione; Hemin; Humans; Mice; Neurites; Sesquiterpenes; Tumor Cells, Cultured | 2001 |
Ammunition against malaria.
Topics: Antimalarials; Artemether; Artemisinins; Canada; Humans; Malaria; Sesquiterpenes | 2001 |
The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu.
Topics: Animals; Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Drugs, Chinese Herbal; Humans; Sesquiterpenes | 1999 |
Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Colorimetry; Diazonium Compounds; Sesquiterpenes; Tablets | 2001 |
Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Reproducibility of Results; Sensitivity and Specificity; Sesquiterpenes | 2002 |
[Pharmacokinetic studies on artemether under conditions simulated in vivo].
Topics: Artemether; Artemisinins; Biological Availability; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Patient Simulation; Sesquiterpenes | 2002 |
Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.
Topics: Acidosis, Respiratory; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Respiratory Insufficiency; Sesquiterpenes | 2004 |
Design of a dissolution system for the evaluation of the release rate characteristics of artemether and dihydroartemisinin from tablets.
Topics: Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Rotation; Sesquiterpenes; Solubility; Solvents; Tablets | 2004 |
[Effects of combined artemether and dihydroarteamisinin in treatment of children with falciparum malaria].
Topics: Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Humans; Malaria, Falciparum | 2005 |
Artesunate and artemether are effective fasciolicides in the rat model and in vitro.
Topics: Animals; Antiplatyhelmintic Agents; Artemether; Artemisinins; Artesunate; Bile Ducts; Disease Models, Animal; Fasciola hepatica; Fascioliasis; Female; Microscopy, Electron, Scanning; Rats; Rats, Wistar; Sesquiterpenes | 2006 |
Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Capsules; Chromatography, High Pressure Liquid; Democratic Republic of the Congo; Dosage Forms; Endemic Diseases; Humans; Kenya; Malaria, Falciparum; Quality Control; Sesquiterpenes; Tablets | 2007 |
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action.
Topics: Animals; Antineoplastic Agents; Artemether; Artemisinins; Artesunate; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2008 |
Antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Therapy, Combination; Ethanolamines; Fats; Fluorenes; Humans; Lumefantrine; Malaria; Quinolines; Treatment Failure | 2009 |
Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Formates; HIV Infections; Humans; Malaria; Models, Chemical; Quality Control; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2009 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chromatography, Liquid; Drug Combinations; Ethanolamines; Fluorenes; Human Experimentation; Humans; Male; Middle Aged; Pakistan; Plasma; Tandem Mass Spectrometry; Time Factors | 2010 |
A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, Liquid; Drug Therapy, Combination; Ethanolamines; Fluorenes; High-Throughput Screening Assays; Humans; Lumefantrine; Malaria, Falciparum; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Male; Rats; Rats, Wistar | 2011 |
Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma.
Topics: Animals; Artemether; Artemisinins; Artesunate; Calibration; Chromatography, Liquid; Chromatography, Reverse-Phase; Glucuronides; Logistic Models; Reproducibility of Results; Sensitivity and Specificity; Sheep; Tandem Mass Spectrometry | 2011 |
Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Mice; Rodent Diseases; Schistosoma japonicum; Schistosomiasis japonica; Treatment Outcome | 2011 |
Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.
Topics: Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Meninges; Papua New Guinea; Prospective Studies | 2011 |
Monitoring of artemisinin, dihydroartemisinin, and artemether in environmental matrices using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Topics: Artemether; Artemisia annua; Artemisinins; Chromatography, High Pressure Liquid; Kenya; Plant Extracts; Soil; Tandem Mass Spectrometry | 2011 |
Metabolite identification of artemether by data-dependent accurate mass spectrometric analysis using an LTQ-Orbitrap hybrid mass spectrometer in combination with the online hydrogen/deuterium exchange technique.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Bile; Chromatography, Liquid; Deuterium Exchange Measurement; Hydroxylation; Male; Mass Spectrometry; Methylation; Microsomes, Liver; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2011 |
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Chromatography; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mass Spectrometry; Models, Statistical; Plasma; Pregnancy; Pregnancy Complications, Infectious; Uganda; Young Adult | 2012 |
Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds.
Topics: Amodiaquine; Analytic Sample Preparation Methods; Artemether; Artemisinins; Butyrylcholinesterase; Cefotaxime; Dried Blood Spot Testing; Drug Stability; Hot Temperature; Humans; Oseltamivir; Pharmaceutical Preparations | 2013 |
Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment.
Topics: Adult; Antimalarials; Antitubercular Agents; Artemether; Artemisinins; Drug Antagonism; Ethanolamines; Female; Fluorenes; HIV Infections; Humans; Longitudinal Studies; Lumefantrine; Male; Rifampin; Tuberculosis; Uganda | 2013 |
Determination of artemether and dihydroartemisinin in human plasma with a new hydrogen peroxide stabilization method.
Topics: Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Humans; Hydrogen Peroxide; Isotope Labeling; Tandem Mass Spectrometry; Temperature | 2013 |
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Topics: Adolescent; Adult; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Quinine; Young Adult | 2013 |
Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Confidence Intervals; Counterfeit Drugs; Enzyme-Linked Immunosorbent Assay | 2013 |
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drug Interactions; Humans; Inhibitory Concentration 50; Microsomes, Liver; Recombinant Proteins; Tandem Mass Spectrometry | 2014 |
A high-performance liquid chromatography-tandem mass spectrometry method for the determination of artemether and dihydroartemisinin in human plasma.
Topics: Artemether; Artemisinins; Chromatography, High Pressure Liquid; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2014 |
Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.
Topics: Age Factors; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Male; Models, Theoretical | 2014 |
[Therapeutic effect of 138 imported falciparum malaria patients].
Topics: Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; China; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Retrospective Studies; Travel; Young Adult | 2014 |
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chemistry Techniques, Synthetic; Malaria, Cerebral; Mice; Molecular Targeted Therapy; Muscle Relaxation; Nitric Oxide Donors; Plasmodium berghei; Rats; Vasodilator Agents | 2015 |
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Case-Control Studies; Coinfection; Drug Combinations; Drug Interactions; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Lumefantrine; Malaria, Falciparum; Male; Nevirapine; Nigeria; Plasmodium falciparum | 2015 |
Genetic Transformation of Artemisia carvifolia Buch with rol Genes Enhances Artemisinin Accumulation.
Topics: Agrobacterium tumefaciens; Antimalarials; Artemether; Artemisia annua; Artemisinins; Artesunate; Base Sequence; Biosynthetic Pathways; Gene Expression Regulation, Plant; Molecular Sequence Data; Plant Proteins; Plants, Genetically Modified; Transformation, Genetic; Trichomes | 2015 |
The Spiroindolone KAE609 Does Not Induce Dormant Ring Stages in Plasmodium falciparum Parasites.
Topics: Antimalarials; Artemether; Artemisinins; Drug Resistance; Erythrocytes; Ethanolamines; Fluorenes; Humans; Indoles; Inhibitory Concentration 50; Life Cycle Stages; Lumefantrine; Plasmodium falciparum; Rhodamine 123; Spiro Compounds | 2016 |
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Quinolines | 2016 |
Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype.
Topics: Adamantane; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inactivation, Metabolic; Lethal Dose 50; Microbial Sensitivity Tests; Peroxides; Plasmodium falciparum; Spiro Compounds | 2016 |
Effects of Dihydroartemisinin and Artemether on the Growth, Chlorophyll Fluorescence, and Extracellular Alkaline Phosphatase Activity of the Cyanobacterium Microcystis aeruginosa.
Topics: Alkaline Phosphatase; Artemether; Artemisinins; Bacterial Proteins; Chlorophyll; Chlorophyll A; Electron Transport; Malondialdehyde; Microcystis; Photosynthesis; Photosystem II Protein Complex; Spectrometry, Fluorescence | 2016 |
A sensitive, high-throughput, and ecofriendly method for the determination of lumefantrine, artemether, and its active metabolite dihydroartemisinin by supercritical fluid chromatography and tandem mass spectrometry.
Topics: Animals; Artemether; Artemisinins; Chromatography, Supercritical Fluid; Ethanolamines; Fluorenes; Lumefantrine; Male; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Tandem Mass Spectrometry; Young Adult | 2018 |
Comparison of in vitro/in vivo blood distribution and pharmacokinetics of artemisinin, artemether and dihydroartemisinin in rats.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Chromatography, Liquid; Drug Monitoring; Injections, Intravenous; Male; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult | 2020 |
A Chemically Stable Fluorescent Mimic of Dihydroartemisinin, Artemether, and Arteether with Conserved Bioactivity and Specificity Shows High Pharmacological Relevance to the Antimalarial Drugs.
Topics: Antimalarials; Artemether; Artemisinins | 2020 |
Leishmania amazonensis response to artemisinin and derivatives.
Topics: Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Leishmania mexicana; Mice; Mice, Inbred BALB C; Parasite Load; Trypanocidal Agents | 2021 |
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines | 2021 |
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection | 2022 |
Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Topics: Artemether; Artemisinins; Artesunate; Caspase 3; Drugs, Chinese Herbal; ErbB Receptors; Humans; Interleukin-17; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Network Pharmacology; Osteoporosis; Prolactin | 2022 |
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells.
Topics: Apoptosis; Artemether; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Tandem Mass Spectrometry; Ursodeoxycholic Acid | 2023 |
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |